Therapy with gemcitabine in pretreated peripheral T-cell lymphoma patients

This publication has 9 references indexed in Scilit:

• Differential Incorporation of Ara-C, Gemcitabine, and Fludarabine Into Replicating and Repairing DNA in Proliferating Human Leukemia Cells
  Blood, 1997
• Predictive capacity of the International Prognostic Factor Index in patients with peripheral T-cell lymphoma.
  Journal of Clinical Oncology, 1997
• Peripheral T-cell lymphomas. Clinico-pathologic study of 168 cases diagnosed according to the R.E.A.L. Classification
  Annals of Oncology, 1997
• Fludarabine- and gemcitabine-induced apoptosis: incorporation of analogs into DNA is a critical event
  Cancer Chemotherapy and Pharmacology, 1995
• A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group [see comments]
  Blood, 1994
• Difluorodeoxycytidine (dFdC) — gemcitabine: A phase I study
  Investigational New Drugs, 1992
• A phase I clinical, plasma, and cellular pharmacology study of gemcitabine.
  Journal of Clinical Oncology, 1991
• Activity of Fludarabine Monophosphate in Patients With Advanced Mycosis Fungoides: A Southwest Oncology Group Study
  JNCI: Journal of the National Cancer Institute, 1990
• Combined modality treatment of cutaneous T cell lymphoma: results of a 6-year follow-up.
  Journal of Clinical Oncology, 1986